About Careers Internship MedBlog Contact us

HIV can Spread to Brain in Four Months Increasing Risk of Dementia

by Dr. Trupti Shirole on March 28, 2015 at 6:03 AM
 HIV can Spread to Brain in Four Months Increasing Risk of Dementia

The human immunodeficiency virus (HIV) that causes AIDS can spread to the patients' brain early in the illness process, revealed a study published in PLoS Pathogens. In the absence of antiretroviral therapy, HIV can genetically evolve and independently replicate in patients' brains as early as four months after initial infection and predisposes an individual to HIV-associated dementia. These findings stress the importance of routine HIV testing to catch the infection as early as possible to allow the prompt initiation of antiretroviral therapy.

Ronald Swanstrom, director, Center for AIDS Research (CFAR), University of North Carolina in the US, informed that one-third of people not taking antiretroviral therapy (ART) to control their HIV will eventually develop HIV-associated dementia.


Researchers followed 72 participants during the first two years of HIV infection. These participants were not taking ART to control their HIV at the time of the study. Through analysis of their cerebral spinal fluid (CSF) and blood samples, 20% of the participants showed replication in the central nervous system (CNS) at four months. Additionally, 30% of participants showed evidence of a marked CSF inflammatory response in at least one time point and 16% of study volunteers showed a marked CSF inflammatory response at multiple time points, suggesting an ongoing infection in the CNS.

Swanstrom said, "This shows that viral replication and inflammation can occur early in infection with the concern being that the damage caused could be irreversible. HIV and inflammation have the potential to accelerate the aging process and cause neurocognitive impairment, in the extreme case resulting in HIV-associated dementia."

Source: Medindia
Font : A-A+



Recommended Readings

Latest AIDS/HIV News

HIV Vaccine Clinical Trial Initiates in the United States and South Africa
The Phase 1 trial for a preventive HIV vaccine candidate has initiated enrollment in both the United States and South Africa.
Beauty Salon-Driven Initiative Boosts PrEP Awareness in Fight Against AIDS
In the United States, African American women make up only 26% of female PrEP users, yet they account for 57% of new infections among women.
Immune-Evading HIV Protein Complex Solved
Scientists have made a groundbreaking discovery in the fight against HIV/AIDS with the successful resolution of the enigmatic immune-evading HIV protein complex.
Does Gender Influence Comorbidity Rates in HIV-Positive Smokers
Tailored quit-smoking programs are designed to address the risks associated with comorbidity in individuals living with HIV.
Digital Test Measures HIV Viral Load
DNA editing tool CRISPR-Cas13 helps diagnose and signal the presence of HIV antibodies in HIV patients.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

HIV can Spread to Brain in Four Months Increasing Risk of Dementia Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests